Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02995395 · ClinicalTrials.gov registry record
Mucosal Impedance Balloon in Diagnosis and Treatment of Eosinophilic Esophagitis (EoE)
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 28
- Enrollment target
NCT02995395: Completed study, sponsored by Mayo Clinic.
NCT02995395 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02995395 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
This study will evaluate the role the balloon mucosal impedance may have in diagnosing and monitoring the patients with Eosinophilic Esophagitis. We will compare the results of the balloon mucosal impedance in patients with Eosinophilic esophagitis and controls.
Primary Outcome
Patient with eosinophilic esophagitis have diminished mucosal impedance, reflecting increased permeability to allergens occurring in the esophagus. The impedance measurements are also variable throughout the esophageal mucosa reflecting the patchy histology of eosinophilic esophagitis.
Interventions
- DEVICE Mucosal Impedance Balloon catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2017-10-01 |
| Est. Completion | 2020-08-31 |
What the finished NCT02995395 record still lists
NCT02995395 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 28 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Mucosal Impedance Balloon catheter is the first listed.
NCT02995395 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02995395 about?
NCT02995395 is a clinical study titled "Mucosal Impedance Balloon in Diagnosis and Treatment of Eosinophilic Esophagitis (EoE)". This study will evaluate the role the balloon mucosal impedance may have in diagnosing and monitoring the patients with Eosinophilic Esophagitis. We will compare the results of the balloon mucosal impedance in patients with Eosinophilic esophagitis and controls.
What is the current status of trial NCT02995395?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2017-10-01. Estimated completion is 2020-08-31.
What interventions are being tested in trial NCT02995395?
The interventions under investigation include: Mucosal Impedance Balloon catheter (DEVICE).
Who is sponsoring clinical trial NCT02995395?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI